Ibere Pharmaceuticals (IBER) Stock Analysis
DELISTED
What happened to Ibere Pharmaceuticals (IBER) stock?
Ibere Pharmaceuticals (IBER) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
P/E 29.94 means the share price is 29.94 times one year of earnings per share. Market cap $176M is the value of all shares combined.
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Ibere Pharmaceuticals (IBER). Ibere Pharmaceuticals is a shell company focused on mergers and acquisitions. As of 2026, it has no significant operations beyond seeking a business combination.
Last analyzed: Mar 18, 2026Ibere Pharmaceuticals (IBER) Financial Services Profile
More about this archive record
Can I still buy IBER shares?
No. IBER stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for IBER elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before IBER stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Ibere Pharmaceuticals. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.